We are leveraging breakthrough technologies to transform drug discovery.
Acquiring detailed knowledge of epitope interactions is critical in the lead validation stage of drug discovery, as it provides insight into the binding mechanism, enabling the optimization of various properties of a drug candidate such as specificity and binding affinity.
Furthermore, a detailed epitope map can provide stronger intellectual property (IP) protection. Epitope claims included in drug patents protect against binders to a specific epitope of the given target, allowing for much broader IP protection.
PLIMB is a revolutionary technique that provides high resolution data on the native, in-solution structure of the therapeutic and target antigen in a rapid analysis that is applicable to a wide range of proteins.
We are leveraging breakthrough technologies to transform drug discovery.
Acquiring detailed knowledge of epitope interactions is critical in the lead validation stage of drug discovery, as it provides insight into the binding mechanism, enabling the optimization of various properties of a drug candidate such as specificity and binding affinity.
Furthermore, a detailed epitope map can provide stronger intellectual property (IP) protection. Epitope claims included in drug patents protect against binders to a specific epitope of the given target, allowing for much broader IP protection.
PLIMB is a revolutionary technique that provides high resolution data on the native, in-solution structure of the therapeutic and target antigen in a rapid analysis that is applicable to a wide range of proteins.